These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 7902161)
1. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. Linnenbach AJ; Pressler LB; Seng BA; Kimmel BS; Tomaszewski JE; Malkowicz SB Hum Mol Genet; 1993 Sep; 2(9):1407-11. PubMed ID: 7902161 [TBL] [Abstract][Full Text] [Related]
2. Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. Poddighe PJ; Bringuier PP; Vallinga M; Schalken JA; Ramaekers FC; Hopman AH J Pathol; 1996 Jun; 179(2):169-76. PubMed ID: 8758209 [TBL] [Abstract][Full Text] [Related]
3. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761 [TBL] [Abstract][Full Text] [Related]
4. Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines. van Tilborg AA; Groenfeld LE; van der Kwast TH; Zwarthoff EC Br J Cancer; 1999 May; 80(3-4):489-94. PubMed ID: 10408858 [TBL] [Abstract][Full Text] [Related]
5. Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Knowles MA; Shaw ME; Proctor AJ Oncogene; 1993 May; 8(5):1357-64. PubMed ID: 8097582 [TBL] [Abstract][Full Text] [Related]
6. Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder. Kimura F; Florl AR; Seifert HH; Louhelainen J; Maas S; Knowles MA; Schulz WA Br J Cancer; 2001 Dec; 85(12):1887-93. PubMed ID: 11747331 [TBL] [Abstract][Full Text] [Related]
7. Role of loss of heterozygosity on chromosomes 8 and 9 in the development and progression of cancer bladder. Abdel Wahab AH; Abo-Zeid HI; El-Husseini MI; Ismail M; El-Khor AM J Egypt Natl Canc Inst; 2005 Dec; 17(4):260-9. PubMed ID: 17102820 [TBL] [Abstract][Full Text] [Related]
8. Role of chromosome 9 in human bladder cancer. Miyao N; Tsai YC; Lerner SP; Olumi AF; Spruck CH; Gonzalez-Zulueta M; Nichols PW; Skinner DG; Jones PA Cancer Res; 1993 Sep; 53(17):4066-70. PubMed ID: 8358736 [TBL] [Abstract][Full Text] [Related]
9. A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. Habuchi T; Yoshida O; Knowles MA Hum Mol Genet; 1997 Jun; 6(6):913-9. PubMed ID: 9175739 [TBL] [Abstract][Full Text] [Related]
10. Frequent p16/MTS1 inactivation in early stages of urothelial carcinoma of the bladder is not associated with tumor recurrence. Friedrich MG; Blind C; Milde-Langosch K; Erbersdobler A; Conrad S; Löning T; Hammerer P; Huland H Eur Urol; 2001 Nov; 40(5):518-24. PubMed ID: 11752859 [TBL] [Abstract][Full Text] [Related]
11. [Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder]. Xiao Z; Zhang J; Zheng S; Li C; He Z; Cheng S; Gao Y Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1375-7. PubMed ID: 12509916 [TBL] [Abstract][Full Text] [Related]
12. Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder. Van Tilborg AA; Hekman AC; Vissers KJ; van der Kwast TH; Zwarthoff EC Int J Cancer; 1998 Jan; 75(1):9-14. PubMed ID: 9426683 [TBL] [Abstract][Full Text] [Related]
13. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder. Natrajan R; Louhelainen J; Williams S; Laye J; Knowles MA Cancer Res; 2003 Nov; 63(22):7657-62. PubMed ID: 14633686 [TBL] [Abstract][Full Text] [Related]
14. High frequency of chromosome 9p allelic loss and CDKN2 tumor suppressor gene alterations in squamous cell carcinoma of the bladder. Gonzalez-Zulueta M; Shibata A; Ohneseit PF; Spruck CH; Busch C; Shamaa M; El-Baz M; Nichols PW; Gonzalgo ML; Elbaz M [corrected to El-Baz M] J Natl Cancer Inst; 1995 Sep; 87(18):1383-93. PubMed ID: 7658499 [TBL] [Abstract][Full Text] [Related]
15. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Keen AJ; Knowles MA Oncogene; 1994 Jul; 9(7):2083-8. PubMed ID: 8208555 [TBL] [Abstract][Full Text] [Related]
16. Deletion mapping of chromosome 11 in carcinoma of the bladder. Shaw ME; Knowles MA Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638 [TBL] [Abstract][Full Text] [Related]
17. Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Habuchi T; Devlin J; Elder PA; Knowles MA Oncogene; 1995 Oct; 11(8):1671-4. PubMed ID: 7478593 [TBL] [Abstract][Full Text] [Related]
18. Molecular genetic analysis of chromosome 9 candidate tumor-suppressor loci in bladder cancer cell lines. Williams SV; Sibley KD; Davies AM; Nishiyama H; Hornigold N; Coulter J; Kennedy WJ; Skilleter A; Habuchi T; Knowles MA Genes Chromosomes Cancer; 2002 May; 34(1):86-96. PubMed ID: 11921286 [TBL] [Abstract][Full Text] [Related]
19. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder. Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332 [TBL] [Abstract][Full Text] [Related]
20. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31. Simoneau M; Aboulkassim TO; LaRue H; Rousseau F; Fradet Y Oncogene; 1999 Jan; 18(1):157-63. PubMed ID: 9926930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]